Semler Scientific Appoints Bitcoin Strategist, Sets Target for 105,000 BTC by 2027

Semler Scientific Inc. (Nasdaq: SMLR) has appointed Joe Burnett as director of Bitcoin strategy and announced plans to accumulate 105,000 Bitcoins by the end of 2027, representing one of the most aggressive corporate Bitcoin acquisition targets announced by a public company, according to a statement on Thursday.

The healthcare technology company, which adopted Bitcoin as its primary treasury reserve asset in May 2024, outlined a three-year accumulation timeline targeting 10,000 BTC by year-end 2025, 42,000 by year-end 2026, and 105,000 by year-end 2027. The company plans to fund these purchases through equity and debt financings alongside operational cash flows.

Semler Scientific became the second U.S. publicly traded company to adopt a Bitcoin treasury strategy, following Strategy's lead. Since implementing its Bitcoin standard, the company reports achieving approximately 287% BTC yield and $177 million in Bitcoin gains through June 3, 2025.

"Joe is an analytical thought leader on Bitcoin and Bitcoin treasury companies," said Eric Semler, chairman of Semler Scientific. "His expertise will be instrumental as we pursue our Bitcoin treasury strategy and aim to deliver long-term value to our stockholders."

Burnett brings seven years of public Bitcoin advocacy and institutional experience to the role. He previously served as director of market research at Unchained, a Bitcoin-focused financial services company, where he contributed to institutional Bitcoin adoption and collaborative custody development.

"We are witnessing the global monetization of Bitcoin as a superior form of money," Burnett said. "Semler Scientific is committed to massively growing its Bitcoin treasury in a highly accretive manner for stockholders, guided by a long-term conviction that Bitcoin is the ultimate long duration asset to hold."

Before joining Unchained, Burnett worked as head analyst and product manager at Blockware Solutions, helping launch one of the largest Bitcoin mining platforms in the United States. He began his career in technology consulting at Ernst & Young and holds a Master's of Science in Business Analytics from the University of Georgia.

Semler Scientific's primary business involves developing healthcare technology products, including its FDA-cleared QuantaFlo device that measures arterial blood flow for chronic disease evaluation. The company's pivot toward Bitcoin treasury management represents a significant strategic shift for the medical technology firm.

The announced Bitcoin accumulation targets would position Semler Scientific among the largest corporate Bitcoin holders globally if achieved. The timeline spans three years, with the company expressing confidence in its ability to execute the strategy through various financing mechanisms.

Corporate Bitcoin adoption has gained momentum since Strategy's initial purchases in 2020, with numerous public companies incorporating cryptocurrency into their treasury strategies as an inflation hedge and store of value.